TERESA DURDEN: Open Payments
NPI 1790763613 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,524 in 71 payments from 11 companies in 2025. Trend: 2023 $517 · 2024 $860 · 2025 $1,524
Food & beverage: $1,524
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $303 |
| AstraZeneca Pharmaceuticals LP | 11 | $238 |
| GlaxoSmithKline, LLC. | 14 | $234 |
| Regeneron Healthcare Solutions, Inc. | 5 | $185 |
| Insmed, Inc. | 8 | $173 |
| Verona Pharma, Inc. | 9 | $143 |
| Viatris Specialty LLC | 5 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
| Amgen Inc. | 2 | $37 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
Products named: DUPIXENT, Arikayce, TEZSPIRE, NUCALA, Ohtuvayre, YUPELRI, TRELEGY ELLIPTA, BREZTRI.
Industry payments across SC — which companies pay providers there.
